2138
E. Kobrzycka et al. / Tetrahedron: Asymmetry 13 (2002) 2133–2139
NMR (125 MHz, toluene-d8, 90°C): l 13.3, 15.4, 28.6,
51.7, 51.9, 59.0, 59.5, 71.5, 71.9, 106.6, 107.9, 125–129
(Ar), 137.0, 151.1, 154.4, 157.0; IR (film): 1696, 2941,
3429 cm−1; LSIMS (+) NBA 402 (M+Na)+; HR EI
C23H25NO4 (M)+ calcd 379.1784, found 379.1779;
[h]2D0=−25.0 (c 1.1, CH2Cl2).
4.4.4.
(4S,5S)-3-Benzyl-4-methyl-5-(5-methylfuran-2-
yl)oxazolidinon-2-one, cis-4. 1H NMR (500 MHz,
CDCl3): l 0.95 (d, J=7.3 Hz, 3H), 2.25 (d, J=0.8 Hz,
3H), 4.17 (AB/2, J=15.3 Hz, 1H), 4.83 (AB/2, J=15.3
Hz, 1H), 5.36 (d, J=8.4 Hz, 2H), 5.91 (dq, J=3.2 Hz,
J=1.0 Hz, 1H), 6.25 (d, J=3.2 Hz, 1H), 7.4–7.3 (m,
5H); 13C NMR (125 MHz, CDCl3): l 13.0, 14.0, 44.9,
53.8, 73.0, 106.2, 110.9, 127–128 (Ar), 136.0, 146.8,
153.2, 157.7; IR (film): 1564, 1753, 2923 cm−1; EI m/z
271 (M)+, 136, 122, 111, 91; HR EI C16H17NO3 (M)+
calcd 271.1208, found 271.1205; [h]2D0=+40.5 (c 0.5,
CH2Cl2).
4.3.7.
(1S,2S)-N-Benzyl,N-[2-(5-methylfuran)-2-yl-2-
hydroxy-1-methylethyl]carbamic acid tert-butyl ester,
anti-3c. Yield 24%; 1H NMR (500 MHz, toluene-d8,
90°C): l 1.09 (d, J=7.1 Hz, 3H), 1.34 (s, 9H), 1.87 (s,
1H), 2.02 (brs, 3H), 4.13 (AB/2, J=15.7 Hz, 1H), 4.47
(AB/2, J=15.7 Hz, 1H), 4.65 (dq, J=5.9 Hz, J=7.1
Hz, 1H), 4.91 (brs, 1H), 5.72 (dq, J=2.3 Hz, J=1.1 Hz,
1H), 6.11 (d, J=2.3 Hz, 1H), 6.9–7.1 (m, 5H); 13C
NMR (125 MHz, toluene-d8, 90°C): l 13.3, 15.4, 28.6,
51.7, 51.9, 59.0, 59.4, 71.5, 71.9, 106.6, 107.9, 125–129
(Ar), 137.7, 151.1, 151.3, 154.0; IR (film): 1564, 1753,
2923 cm−1; EI m/z 335 (M)+, 271, 124, 178, 134; HR EI
C20H27NO4 (M)+ calcd 345.1940, found 345.1936. Anal.
calcd for C20H27NO4: C, 69.54; H, 7.88; N, 4.06. Found
C, 69.51; H, 7.92; N, 4.04%. [h]2D0=+25.3 (c 0.9,
CH2Cl2).
4.5. (1S,2S)-N-Benzyl-N-[2-(5-methylfuran-2-yl)-2-
triphenylsilanyloxy-1-methylethyl]-4-methylbenzenesul-
fonamide, 5
1H NMR (500 MHz, CDCl3): l 1.37 (d, J=6.9 Hz,
3H), 1.90 (s, 3H), 2.00 (s, 3H), 3.92 (AB/2, J=15.7 Hz,
1H), 4.43 (AB/2, J=15.7 Hz, 1H), 4.63 (dq, J=8.4 Hz,
J=6.9 Hz, 1H), 4.91 (d, J=8.4 Hz, 1H), 5.53 (dq,
J=3.1 Hz, J=1.0 Hz, 1H), 5.75 (d, J=3.1 Hz, 1H),
6.9–7.2 (m, 20H), 7.55 (m, 4H); 13C NMR (125 MHz,
CDCl3): l 13.2, 16.2, 20.1, 49.4, 58.7, 72.3, 106.5, 110.7,
140–127 (Ar), 151.2, 152.1; IR (KBr): 1114, 1150, 1338,
3068 cm−1; LSIMS (+) NBA 680 (M+Na)+; mp=135–
136°C [h]2D0=−39.3 (c 1.1, CH2Cl2).
4.4. Chemical correlations
4.4.1. Oxazolidinone formation under acidic conditions.
To a solution of anti-3b or anti-3c (0.3 mmol) in
CH2Cl2 (10 mL) was slowly added CF3CO2H (1.5
mmol). After 1 h stirring at rt, the reaction mixture was
diluted with water (5 mL) and extracted with Et2O
(2×10 mL). The combined organic phases were washed
with brine (10 mL), dried over MgSO4. Flash chro-
matography (hexanes/AcOEt, gradually from 9:1 to
7:3) afforded a mixture of oxazolidinones 4.
4.5.1. X-Ray crystallography of compound 5. X-Ray
diffraction measurement of the suitable crystal com-
pound 5 was carried out with a Nonius MACH3 dif-
fractometer using graphite monochromated Cu Ka
radiation (see Table 5). Intensities were collected at
room temperature using ꢀ–2q scan technique. Intensity
of the three control reflections measured every 200
reflections showed no loss of intensity. The data were
corrected for Lorentz and polarisation factors. The
structure was solved by direct methods18 [xray 1] and
refined by a full-matrix least-squares procedure with the
use of the SHELXL program19 [xray 2]. The non-
hydrogen atoms were refined anisotropically, whereas
H-atoms were placed at their calculated positions and
4.4.2. Oxazolidinone formation using BuLi. To a pre-
cooled (−20°C) solution of 3b (0.05 mmol) in dry THF
(10 mL) was slowly added a solution of BuLi in hexane
(1.6 M, 0.06 mmol). The reaction mixture was allowed
to reach rt and was stirred at that temperature for 1 h.
The mixture was diluted with water (25 mL) and
extracted with Et2O (2×10 mL). The combined organic
phases were washed with brine (10 mL), HCl (1 M, 10
mL), satd NaHCO3aq (10 mL) and again with brine (10
mL) and dried over MgSO4. Flash chromatography
(hexanes/AcOEt, gradually from 9:1 to 7:3) afforded a
mixture of oxazolidinones cis-4 in the yield of 96%.
Table 5. Crystallographic data and refinement details for 5
Empirical formula
Formula weight
Wavelength (A)
Crystal system
Space group
Unit cell dimensions
C40H39NO4SSi
657.87
,
1.54178
Orthorhombic
P212121
4.4.3.
(4S,5R)-3-Benzyl-4-methyl-5-(5-methylfuran-2-
yl)oxazolidinon-2-one, trans-4. 1H NMR (500 MHz,
CDCl3): l 1.21 (d, J=7.3 Hz, 3H), 2.23 (d, J=0.8 Hz,
3H), 4.17 (AB/2, J=15.3 Hz, 1H), 4.82 (AB/2, J=15.3
Hz, 1H), 4.85 (d, J=7.3 Hz, 2H), 5.91 (dq, J=3.2 Hz,
J=0.8 Hz, 1H), 6.22 (d, J=3.2 Hz, 1H), 7.32 (m, 5H);
13C NMR (125 MHz, CDCl3): l 13.5, 17.6, 46.0, 54.4,
76.5, 106.5, 111.3, 127–128 (Ar), 135.9, 147.2, 153.9,
157.3; IR (film): 1565, 1755, 2923 cm−1; EI m/z 271
(M)+, 136, 122, 111, 91; HR EI C16H17NO3 (M)+ calcd
271.1208, found 271.1209; [h]2D0=−144.5 (c 1.3,
CH2Cl2).
,
a (A)
10.819(2)
12.065(2)
54.622(5)
7130(2)
,
b (A)
,
c (A)
Volume (A )
3
,
Z
8
Absorption coefficient (mm−1
Reflections collected
Independent reflections
Data/restrains/parameters
Final R indices [I\2|(I)]
Absolute structure parameter
)
1.453
7896
7130 [R(int)=0.0278]
7130/0/848
R1=0.0448, wR2=0.1173
0.01(2)